MILFORD, CT (July 5, 2016) – Kubtec®, the leader in innovation for breast specimen imaging and neonatal radiography, announced today that two of its groundbreaking products have been honored at the Premier, Inc. 2016 Annual Breakthroughs Celebration in Washington, DC.

Earlier this summer, New York Gov. Andrew M. Cuomo signed legislation to increase access to breast cancer screening throughout the state.

Observing eye-movement patterns in radiologists interpreting scans, researchers in Finland have shown that the eyes are—so to speak—a window into the soul of expertise and the level of experience. 

A team of Harvard radiologists is advising fellow rads to bone up on imaging-evident drug toxicity so as to shed their reputation as providers of a standalone service and, more to the point, cement their role as central members of the cancer team in this era of precision oncology. 

The American College of Radiology has updated its manual on the use of contrast media, emphasizing in press materials the guidelines’ revised take on gadolinium in response to communications over concerns from the FDA and others.

Noting that endometrial cancer (EC) is the most common cancer of the female reproductive organs, an expert panel reports that it has developed and refined ACR appropriateness criteria on the management of patients with recurrent EC across its most common clinical variants. 

A new treatment is now an FDA-approved option for patients with essential tremor. On July 11, the agency approved using an MRI-guided focused ultrasound to treat essential tremor cases that haven’t responded to medication. 

Breast lumps found between scheduled screening mammograms are better evaluated with targeted ultrasound than with repeat mammography, as the latter doesn’t add value beyond the former and so may only increase expense as well as radiation exposure.